Table 2. View Large | American Society of Hematology

Table 2.

Role of novel agent-based combinations in patients with a high-risk cytogenetic abnormality (CA)

Role of novel agent-based combinations in patients with a high-risk cytogenetic abnormality (CA)

This Feature Is Available To Subscribers Only

Sign In or Create an Account